Intravenous Hydration Therapy Market To Reach $4.23 Billion By 2030

Intravenous Hydration Therapy Market Growth & Trends

The global intravenous hydration therapy market size is expected to reach USD 4.23 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is expected to register a CAGR of 7.97% from 2023 to 2030. The increasing adoption and awareness regarding procedures that aid in providing fast action and the growing adoption of beautification procedures are expected to provide growth opportunities to the market. IV hydration therapy is a medical treatment that involves administering electrolytes, vitamins, and fluids directly into the bloodstream through an intravenous (IV) catheter.

The therapy is intended to give effective and rapid nutrient replenishment and rehydration to anyone suffering from vitamin deficiencies, dehydration, or other medical problems. IV hydration therapy is one of the most efficient methods of delivering critical fluids to the body. The therapy has been widely adopted during the pandemic and during the severe influenza season. Severe influenza seasons and adverse weather events have contributed to IV fluid shortages in the U.S. in recent years. Due to these shortages, healthcare facilities and professionals have been forced to employ alternative approaches or postpone patient treatments.

Moreover, there are several investments in the field of hydration therapy in order to increase production capacity and make the technique better available to the target audience. For instance, in December 2022, REVIV launched a new and exclusive IV therapy infusion clinic in Harrods that offers IV hydration therapy. Clinics, medical spas, and various other facilities are actively investing in adopting the procedure in their healthcare settings, owing to an increasing demand among the target population.

Some of the benefits offered by IV hydration therapy include the treatment of various conditions such as dehydration occurring due to alcohol consumption, illness, exercise, fatigue, migraine, and other immune system deficiencies. This factor is further expected to propel the industry’s growth. Key players operating in the market are focusing on product launches that may help enhance IV hydration therapy adoption.

For instance, in July 2022, Sameday Health announced the launch of the Inner Beauty IV drip therapy. The drip contains vitamin B complex vitamins and Vitamin C that would help in reducing wrinkles, fortifying the nails and hair, and hydrating the skin. The therapy has been made available at Sameday Health clinics across the globe.

 Request a free sample copy or view report summary: Intravenous (IV) Hydration Therapy Market Report

Intravenous Hydration Therapy Market Report Highlights

• By service, the energy boosters segment held the largest share in 2022 and is expected to expand at a significant CAGR over the forecast period. This can be attributed to the extensive use of infusions with added nutrients by athletes to boost their energy levels

• By component, the medicated segment held the largest share in 2022 and is expected to advance at a substantial growth rate over the forecast period. The segment growth is due to the rising use of infusions having added medication for treating various dehydration-related illnesses

• Based on end-use, the hospitals & clinics segment held the dominant share of the market in 2022 and is expected to witness strong growth over the forecast period. This can be attributed to the increasing number of hospitalizations owing to the rising prevalence of immunity disorders

• North America dominated the market in 2022 with the largest revenue share, owing to the increasing prevalence of chronic conditions, growing investments in production facilities, and the advent of the severe influenza season every year

• The market is fragmented, with the presence of few major players in the market. These players are adopting several strategies, including product launches and technological advancements, to gain a competitive share

Intravenous Hydration Therapy Market Segmentation

Grand View Research has segmented the global IV hydration therapy market based on service, component, end-use, and region:

IV Hydration Therapy Service Outlook (Revenue, USD Billion, 2018 - 2030)

• Immune Boosters

• Energy Boosters

• Skin Care

• Migraine

• Others

IV Hydration Therapy Component Outlook (Revenue, USD Billion, 2018 - 2030)

• Medicated

• Non-medicated

IV Hydration Therapy End-use Outlook (Revenue, USD Billion, 2018 - 2030)

• Hospitals & Clinics

• Wellness Centers & Spas

• Home Healthcare

• Others

IV Hydration Therapy Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Intravenous Hydration Therapy Market

• Core IV Therapy, LLC

• Cryojuvenate UK Ltd.

• B. Braun Medical Inc.

• Otsuka Pharmaceutical Co., Ltd.

• NexGen Health

• JW Life Science Corporation

• Amanta Healthcare

• Baxter International Inc.

• Drip Hydration